Disc Medicine, Inc.
IRONCIK 0001816736
Revenue (TTM)
—
Q1 Apr 2026
Net Income (TTM)
−$215.16M
−94.0% YoY
Q1 Apr 2026
EPS Diluted (TTM)
−$6.02
−51.8% YoY
Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
—
Q1 Apr 2026
Free Cash Flow (TTM)
−$173.62M
Q1 Apr 2026
Cash
$88.91M
Q1 Apr 2026
Total Debt
$29.37M
Q1 Apr 2026
Shares Outstanding
38.2M sh
Q1 Apr 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.